FDA warns drug companies selling unapproved narcotic pain meds

FDA warns drug companies selling unapproved narcotic pain meds


FDA warns drug companies like Glenmark Pharmaceuticals to stop making illegal meds.

Dallas, TX (JusticeNewsFlash.com)–The United States Food and Drug Administration (FDA) www.fda.gov initiated another crack down on nine pharmaceutical manufacturing on Tuesday. Federal regulators issued warnings to drug makers, like Boehringer Ingelheim’s Roxane Inc unit, Covidien Ltd’s Mallinckrodt unit and Glenmark Pharmaceuticals, to stop selling 14 unapproved narcotic pain medications, as reported by Reuters.

The generic prescription drug companies must stop making unapproved versions of morphine, hydromorphone, and oxycodone within 60 days and stop all shipments within 90 days. The federal government’s health and law initiative wants to eliminate medications being sold to American consumers which have not been properly cleared and approved by the FDA. Mismanaged narcotic pain medications, and drugs with versions of the above generic formulas, have caused widespread injuries, illnesses, addictions, and even deaths across the nation.

By: Dallas Drug Injury Lawyer Amy K. Witherite –  Amy Witherite. Eberstein & Witherite, LLP. 3100 Monticello Avenue, Suite 500. Dallas, TX 75205 – Toll Free: (888) 407-6669

More to explorer

Understanding Key Factors in Accidents

Pedestrian Safety Statistics Pedestrian safety is an urgent concern worldwide, with over 1.3 million people dying in traffic accidents annually. Pedestrians account